Scrip: industry news and insights
Vera Pins Hopes On Per-Protocol Analysis To Revive Phase II IgAN Asset
31 Jan 2023
The US firm is shifting its focus to IgAN after a promising new prespecified analysis of its Phase II trial...
Watch the Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019 webinar video recording below:
Webinar agenda:
The drug R&D pipeline in 2019, and how it is changing
The outlook for pharma for the year ahead
Scrip: industry news and insights
31 Jan 2023
The US firm is shifting its focus to IgAN after a promising new prespecified analysis of its Phase II trial...
Scrip: industry news and insights
31 Jan 2023
The Swedish biotech is stepping up its business development plans ahead of a mid-stage readout in the summer for ACD440...
Scrip: industry news and insights
31 Jan 2023
Comirnaty was the industry’s top-selling product through the first three quarters of 2022, as in 2021, but Paxlovid proved a...
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: